Targeting DLL3: Innovative Strategies for Tumor Treatment

Targeting DLL3: Innovative Strategies for Tumor Treatment

Delta-like 3 (DLL3) is an oncogenic protein aberrantly expressed in several tumors, particularly in small-cell lung cancer. DLL3-targeted therapies have recently made significant progress, demonstrating promising preclinical and clinical efficacy. This review aims to explore the mechanisms, challeng...

Full description

Saved in:
Bibliographic Details
Main Authors: Hui Wang, Tong Zheng, Dan Xu, Chao Sun, Daqing Huang, Xiongxiong Liu
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Pharmaceutics
Subjects:
DLL3
targeted therapy
solid tumor
clinical trials
Online Access:https://www.mdpi.com/1999-4923/17/4/520
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items